Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Rossi

Showing results (21-30 of 439) with videos related to

Pageof 44
Sort By:
Journal of Clinical Medicine|June 10, 2023
Gilteritinib: The Story of a Proceeding Success into Hard-to-Treat Matteo Molica, Salvatore Perrone, Marco Rossi
Proceedings. Mathematical, Physical, and Engineering Sciences|November 19, 2019
Swelling and shrinking in prestressed polymer gels: an incremental stress-diffusion analysisMarco Rossi, Paola Nardinocchi, Thomas Wallmersperger
Journal of the Korean Association of Oral and Maxillofacial Surgeons|May 3, 2017
A rare case of osteonecrosis of the jaw related to imatinibMassimo Viviano, Marco Rossi, Serena Cocca
Annals of Translational Medicine|January 7, 2016
MicroRNAs in multiple myeloma and related bone diseaseMarco Rossi, Pierosandro Tagliaferri, Pierfrancesco Tassone
Journal of Clinical Anesthesia|December 12, 2018
Feed and swaddle for neonatal brain MRI: Take stock of the situation!Fabio Sbaraglia, Rossella Garra, Marco Rossi
Journal of Nanoscience and Nanotechnology|September 11, 2015
A Special Section on Nanodiamonds for Biomedical ApplicationsMaria Letizia Terranova, Silvia Orlanducci, Marco Rossi
The American Journal of Case Reports|June 30, 2021
Roxithromycin-Associated Acute ThrombocytopeniaMarco Rossi, Matteo Capecchi, Pietro E Lazzerini
Expert Review of Anticancer Therapy|November 19, 2025
Ropeginterferon alfa-2b in polycythemia vera: redefining disease control through molecular targetingLaura De Fazio, Matteo Molica, Marco Rossi
Mediterranean Journal of Hematology and Infectious Diseases|November 13, 2024
Sustained Remission in an Elderly Patient with Acute Myeloid Leukemia Following Gilteritinib Treatment as Third-Line Salvage TherapyMatteo Molica, Laura De Fazio, Marco Rossi
Journal of the Neurological Sciences|February 24, 2009
Prulifloxacin as a trigger of myasthenia gravisMarco Rossi, Gaia Lusini, Alessia Biasella, et al.
Pageof 44

Showing results (21-30 of 439) with videos related to

Sort By:
Pageof 44
Journal of Clinical Medicine|June 10, 2023
Gilteritinib: The Story of a Proceeding Success into Hard-to-Treat Matteo Molica, Salvatore Perrone, Marco Rossi
Proceedings. Mathematical, Physical, and Engineering Sciences|November 19, 2019
Swelling and shrinking in prestressed polymer gels: an incremental stress-diffusion analysisMarco Rossi, Paola Nardinocchi, Thomas Wallmersperger
Journal of the Korean Association of Oral and Maxillofacial Surgeons|May 3, 2017
A rare case of osteonecrosis of the jaw related to imatinibMassimo Viviano, Marco Rossi, Serena Cocca
Annals of Translational Medicine|January 7, 2016
MicroRNAs in multiple myeloma and related bone diseaseMarco Rossi, Pierosandro Tagliaferri, Pierfrancesco Tassone
Journal of Clinical Anesthesia|December 12, 2018
Feed and swaddle for neonatal brain MRI: Take stock of the situation!Fabio Sbaraglia, Rossella Garra, Marco Rossi
Journal of Nanoscience and Nanotechnology|September 11, 2015
A Special Section on Nanodiamonds for Biomedical ApplicationsMaria Letizia Terranova, Silvia Orlanducci, Marco Rossi
The American Journal of Case Reports|June 30, 2021
Roxithromycin-Associated Acute ThrombocytopeniaMarco Rossi, Matteo Capecchi, Pietro E Lazzerini
Expert Review of Anticancer Therapy|November 19, 2025
Ropeginterferon alfa-2b in polycythemia vera: redefining disease control through molecular targetingLaura De Fazio, Matteo Molica, Marco Rossi
Mediterranean Journal of Hematology and Infectious Diseases|November 13, 2024
Sustained Remission in an Elderly Patient with Acute Myeloid Leukemia Following Gilteritinib Treatment as Third-Line Salvage TherapyMatteo Molica, Laura De Fazio, Marco Rossi
Journal of the Neurological Sciences|February 24, 2009
Prulifloxacin as a trigger of myasthenia gravisMarco Rossi, Gaia Lusini, Alessia Biasella, et al.
Pageof 44